Market Vectors And Strategic Opportunities In Oxygen Markets
|
|
Oxygen at home is delivered via three modalities, oxygen concentrators, liquid oxygen, and high pressure oxygen. Changes in usage patterns are occurring. Supplemental oxygen is frequently prescribed for patients with a variety of disease conditions. For patients with these conditions, oxygen helps fuel brain and muscle cells. It also eases the workload of the heart. New treatment modalities are changing oxygen therapy. Supplemental oxygen is fundamental to life for people that need it. Demand for oxygen is expected to continue. Revision of the care delivery process is anticipated as managed care providers seek to manage care delivery for respiratory disease. Physician oxygen prescriptions are shifting as research provides more information about what works. The flow rate is determined by the amount of oxygen needed to fuel active muscles. During exercise, more oxygen is needed than during sleep when blood oxygen levels naturally fall. Oxygen conservation devices permit some efficiencies of care delivery.
OXYGEN CONCENTRATORS:
MARKET
VECTORS AND STRATEGIC
OPPORTUNITIES
Oxygen
concentrator markets promise to grow across as new technologies significantly
reduce the size and weight of units. The
growth and strategies are documented in this all new study from WinterGreen
Research. The Technology promises
to be the primary market driver as home health care markets achieve
significant growth from the decrease in hospital length of stay.
Key Findings of Study
Market
Directions/Opportunities
·
Further cuts in oxygen
reimbursement are a virtual certainty
·
Reimbursement drives markets
·
New technologies are evolving
·
Portability of units is a
driving design objective
·
Several new oxygen concentrator
technologies appear to hold promise
·
Companies are changing
direction
·
More medical care delivery is
anticipated to occur in the home and alternate site arenas
·
Care delivery is moving out of
the hospital
·
Growth of oxygen concentrator
markets is being fueled by an increase in respiratory disease
·
Other growth factors include
the aging of the population, renewed interest in patient mobility, and demands
for better care delivery
·
Increasing influence of HMO and
managed care providers on the delivery of homecare services
The Study Addresses:
·
Market segments likely to have strong and sustained growth
·
The potential for new technologies to impact markets
·
Strategic positioning of oxygen company participants
·
Market directions and strategic market alliances
·
Risk/reward scenarios -- Access to existing customer bases
·
Strategies for success
market vectors and strategic opportunities in oxygen markets
Oxygen at home is delivered via three modalities, oxygen concentrators,
used an estimated 80% of the time, liquid oxygen, and high pressure oxygen.
Supplemental oxygen is frequently prescribed for patients with a
variety of disease conditions. For patients with these conditions, oxygen
helps fuel brain and muscle cells. It also eases the workload of the heart.
No new treatment modalities loom to replace oxygen therapy and oxygen
therapy is fundamental to life for people that need it.
Demand for oxygen is expected to continue. Some revision of the care delivery process is anticipated as
managed care providers seek to eliminate fraud and initiate good business
management practices on the delivery of care for respiratory disease.
Oxygen must be prescribed by a physician.
The flow rate is determined by the amount of oxygen needed to fuel
active muscles. During exercise,
more oxygen is needed than during sleep when blood oxygen levels naturally
fall. Oxygen conservation devices
permit some efficiencies of care delivery.
If you have any of these questions
What strategies hold promise
Where are the opportunities
How will markets unfold
Why will new technologies evolve new product designs
Which service configurations position providers with competitive advantage
You NEED this study
REPORT OUTLINE
TABLE OF CONTENTS
EXECUTIVE SUMMARY
CHAPTER SUMMARIES
MARKET PROFILE
MANAGED CARE
HOME CARE MARKET PARAMETERS
INCIDENCE OF RESPIRATORY
DISEASE
PROFESSIONALS
OVERVIEW OF OXYGEN EQUIPMENT
OXYGEN CONCENTRATORS
HEALTHDYNE
DEVILBISS
INVACARE
NELLCOR/PURITAN-BENNETT
AIRSEP
AEQUITRON
NIDEK MEDICAL
EVEREST & JENNINGS
TIMETER OXYGEN CONCENTRATOR
LIQUID OXYGEN
REASONS FOR PRESCRIBING LIQUID OXYGEN
PURITAN-BENNETT
CAIRE/MVE/CRYOGENIC ASSOCIATES
PULSAIR/DEVILBISS/SUNRISE
PENOX
COMPRESSED GAS OXYGEN
CYLINDERS
CHAD THERAPEUTICS
MADA
DEVILBISS
OXYGEN CONSERVATION DEVICES
PULSAIR OXYGEN CONSERVATION DEVICE
CHAD
VICTOR
HIGH PRESSURE OXYGEN SYSTEMS
OXYGEN MARKET FORCES
OXYGEN MARKETS
CHANGES IN OXYGEN
REIMBURSEMENT
LIQUID OXYGEN
OXYGEN CONCENTRATORS
HIGH PRESSURE OXYGEN
OXYGEN CONSERVATION DEVICES
MARKET PROFILE
HOMECARE DEALERS
HOMECARE DEALER PROFILE
RESPIRATORY DISEASE INCIDENCE
CHRONIC
ACUTE
FORECASTS 1994-2000
OXYGEN CONCENTRATORS
LIQUID OXYGEN
COMPRESSED GAS OXYGEN
CYLINDERS
OXYGEN CONSERVATION DEVICES
HIGH PRESSURE OXYGEN SYSTEMS
MARKET SHARES
OXYGEN CONCENTRATORS
STRATEGIES
FACTORS DRIVING GROWTH
STRATEGIC POSITIONING FOR
OXYGEN CONCENTRATORS
NEW TECHNOLOGY
REPORT METHODOLOGY
This is the twelfth in a series of market forecasts of respiratory
disease equipment and oxygen businesses.
The project leaders have significant experience preparing industry
studies. Forecasts are based on
primary research and proprietary data bases.
In-depth interviews are conducted with a broad range of key
participants in the market.
about the company
WinterGreen Research, founded in 1985, provides strategic market
assessments in telecommunications, communications equipment, health care and
advanced computer technology. Industry
reports focus on opportunities that will expand existing markets or develop
major new markets. The reports
assess new product and service positioning strategies; new and evolving
technologies; and technological impacts on products, services, and markets.
Market shares are estimated. Leading
market participants are profiled, and their marketing strategies, acquisitions,
and strategic alliances are discussed. The
principals of WnterGreen Research have been involved in analysis and forecasting
of international business opportunities in telecommunications and advanced
computer technology markets for over 30 years.
about the principal authors
Ellen T. Curtiss, President, co-founder of WinterGreen Research,
conducts strategic and market assessments in technology-based industries.
Previously she was a member of the staff of Arthur D. Little, Inc., for
23 years, most recently as Vice President of Arthur D. Little Decision
Resources, specializing in strategic planning and market development services.
A graduate of Boston University and the Program for Management
Development at Harvard Graduate School of Business Administration, she is a
Chartered Financial Analyst.
Susan Eustis, Vice President, co-founder of WinterGreen Research,
has done research in communications and computer markets and applications.
She holds several patents in microcomputing and parallel processing.
She is the author of recent studies of the Regional Bell Operating
Companies' marketing strategies and of a study of telecommunications company
positioning in the European market. Ms.
Eustis is a graduate of Barnard College.
Order Form
Return to:
WinterGreen Research, Inc.
Tel (617) 863-5078
6 Raymond Street
Fax (617) 863-1235
Lexington, MA 02173 USA
Please
enter my order for:
OXYGEN CONCENTRATORS: MARKET
VECTORS AND STRATEGIC OPPORTUNITIES, FORECASTS
TO 2000
____Enclosed
is my check for $2800
____Please
bill my company using P.O. Number______________________
____Please
charge my American Express Card Number __________________ Exp. Date____
____Please
charge my MasterCard/Visa Card Number __________________ Exp. Date____
______Additional
copies, @ $375 (Extra copy price in effect only with initial order)
Signature x
Date
Name
Title
Company
Division
Address
City
State
Zip
Telephone
Fax
Please
Note: Residents of Massachusetts
and Connecticut must include appropriate sales tax.
Subscribers outside the United States must provide prepayment in U.S. Funds
|
|
|
|
|
|
|
|
|
|
